Cargando…
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
PURPOSE: A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens. METHODS: This multicentre, randomized, open-lab...
Autores principales: | Celio, Luigi, Frustaci, Sergio, Denaro, Angela, Buonadonna, Angela, Ardizzoia, Antonio, Piazza, Elena, Fabi, Alessandra, Capobianco, Alba Maria, Isa, Luciano, Cavanna, Luigi, Bertolini, Alessandro, Bichisao, Ettore, Bajetta, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128271/ https://www.ncbi.nlm.nih.gov/pubmed/20574663 http://dx.doi.org/10.1007/s00520-010-0941-7 |
Ejemplares similares
-
Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron
por: Bajetta, Emilio, et al.
Publicado: (2009) -
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
por: Kang, Jin Hyoung, et al.
Publicado: (2020) -
Palonosetron: A novel approach to control postoperative nausea and vomiting in day care surgery
por: Bajwa, Sukhminderjit Singh, et al.
Publicado: (2011) -
Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy
por: Affronti, Mary Lou, et al.
Publicado: (2014) -
One‐Day Versus Three‐Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy‐Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data‐Based Meta‐Analysis
por: Okada, Yuki, et al.
Publicado: (2019)